E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 6/28/2005 in the Prospect News Biotech Daily and Prospect News Convertibles Daily.

Lonza CHF 330 million convertible talked to yield 1.125%-1.625%, up 30%-35%

Nashville, June 28 - Lonza Group AG on Tuesday launched a CHF 330 million convertible talked with a coupon range of 1.25% to 1.625% and initial conversion premium of between 30% and 35%.

Credit Suisse First Boston and Deutsche Bank Securities are joint bookrunners of the deal, which was expected to price Tuesday or Wednesday, according to market sources.

The four-year bond may be increased by CHF 50 million, in addition to there being a CHF 50 million greenshoe available.

The Swiss pharmaceuticals and chemicals concern has earmarked proceeds to refinance debt due next year and for general purposes.

Lonza shares spent much of Tuesday's session in lower territory but closed the day higher by CHF 0.30, or 0.43%, at CHF 69.80 in Europe.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.